Navigation Links
How to make high-end perfumes without whale barf
Date:4/4/2012

University of British Columbia researchers have identified a gene in balsam fir trees that could facilitate cheaper and more sustainable production of plant-based fixatives and scents used in the fragrance industry and reduce the need for ambergris, a substance harvested from whale barf.

When sperm whales consume sharp objects, such as seashells and fish bones, their gut produces a sticky substance to protect their digestive organs. They then regurgitate the mixture much like cats throwing up fur balls and the vomit, reacting with seawater, turns into rock-like objects that wash ashore. These are collected and refined for their fixative properties. Called ambergris, the scented compound is added to high-end perfumes to help the fragrance stay on the skin longer.

The discovery was led by Prof. Joerg Bohlmann and postdoctoral research associate Philipp Zerbe at UBC's Michael Smith Laboratories. Details are published in the April 6 issue of the Journal of Biological Chemistry.

"The use of ambergris in the fragrance industry has been controversial," says Bohlmann, who is a professor of Botany and Forest Sciences. "First of all, it's an animal byproduct and the use of such in cosmetics has been problematic, not to mention it comes from the sperm whale, an endangered species."

Even though much of the ambergris approved for use today is manually collected along the shorelines of known sperm whale habitats in the Atlantic and Pacific Oceans and in the Caribbean, it is still a costly venture. In the Mediterranean, sage has been cultivated for the production of a plant-based substitute of ambergris, but yields are variable and can be unpredictable, similar to manual collection of ambergris.

"We've now discovered that a gene from balsam fir is much more efficient at producing such natural compounds, which could make production of this bio-product less expensive and more sustainable," says Bohlmann.

The discovery and related technology is currently being commercialized through UBC's Industry Liaison Office. The research was supported by Genome Canada, Genome British Columbia, and Genome Alberta through the PhytoMetaSyn Project, and through grants from the Natural Sciences and Engineering Research Council of Canada.


'/>"/>

Contact: Joerg Bohlmann
bohlmann@msl.ubc.ca
604-822-0282
University of British Columbia
Source:Eurekalert

Related biology news :

1. Even natural perfumes may cause allergies
2. No entry without protein recycling: RUB researchers discover new coherence in enzyme transport
3. Potatoes lower blood pressure in people with obesity and hypertension without increasing weight
4. No future without scarce metals
5. System to deliver organ transplant drug -- without harmful side effects
6. A new method for testing allergenic substances without experimental animals
7. Green routing can cut car emissions without significantly slowing travel time
8. Alternate ending -- living on without telomerase
9. Growing without cell division
10. Researchers do precise gene therapy without a needle
11. Can antivirulence drugs stop infections without causing resistance?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/15/2016)... Research and Markets has announced the addition ... report to their offering. ... The global ... from USD 6.21 Billion in 2016, growing at a CAGR of ... bioinformatics market is driven by the growing demand for nucleic acid ...
(Date:11/14/2016)... , Nov. 14, 2016  Based on ... market, Frost & Sullivan recognizes FST Biometrics ... Award for Visionary Innovation Leadership. FST Biometrics ... biometric identification market by pioneering In Motion ... for instant, seamless, and non-invasive verification. This ...
(Date:6/22/2016)... June 22, 2016  The American College of Medical Genetics ... Executive Magazine as one of the fastest-growing trade shows ... at the Bellagio in Las Vegas . ... percentage of growth in each of the following categories: net ... and number of attendees. The 2015 ACMG Annual Meeting was ...
Breaking Biology News(10 mins):
(Date:12/5/2016)... CALGARY , Dec. 5, 2016 /PRNewswire/ - ... announced  that the independent Data and Safety Monitoring ... trial in high-risk cardiovascular disease (CVD) patients has ... that the study should continue as planned without ... and noted that no safety or efficacy concerns ...
(Date:12/5/2016)... N.J. , Dec. 5, 2016  Eisai ... 3 open-label two-year study of rufinamide, which were ... American Epilepsy Society (AES) held from December 2-6 ... of final two-year safety, tolerability and cognitive data ... rufinamide experienced similar safety and tolerability profiles, cognitive ...
(Date:12/5/2016)... , December 5, 2016 The ... with almost $108 billion of revenue and some $890 ... were spent on global biopharmaceuticals, and this figure is ... Stock-Callers.com has lined up these four equities for assessment: ... Pharmaceuticals Inc. (NASDAQ: ACAD ), Acorda Therapeutics ...
(Date:12/4/2016)... ... December 03, 2016 , ... ... A microbiome impact grant award has been made to Dr. Renato Polimanti of ... and drinking on the oral microbiome. Grant proposals have been vetted by the ...
Breaking Biology Technology: